Navigation Links
The Lanier Law Firm Will Appeal Court Reversal of Jury Award to Widow in Nation's 1st Vioxx Trial
Date:5/29/2008

HOUSTON, May 29 /PRNewswire/ -- The Lanier Law Firm is announcing its plans to appeal a decision issued today by the 14th Court of Appeals in Brazoria County in favor of Whitehouse Station, N.J.-based Merck & Co. (NYSE: MRK). In the ruling, the court overturned a jury's determination that the controversial painkiller Vioxx caused the death of a 59-year-old triathlete who died after taking the drug for less than nine months.

"Activist judges are protecting corporate executives and stripping away the rights of widows and every other victim of corporate misconduct. We are filing an appeal," says attorney Mark Lanier, lead counsel for plaintiff Carol Ernst and founder of The Lanier Law Firm. "This decision was handed down by a group of judges who regularly accept campaign contributions from law firms representing corporations that appear in their courts. We will appeal this decision to the United States Supreme Court if necessary."

Vioxx was withdrawn from the U.S. market in September 2004 after studies revealed that the popular pain medication was responsible for substantially increasing the rate of heart attacks among patients.

Mr. Lanier represented Mrs. Ernst in the nation's first Vioxx trial in August 2005. After hearing more than a month of testimony from both sides, a jury of 12 residents from Angleton, Texas, issued a verdict of $253 million in favor of Mrs. Ernst. The verdict was later reduced to $26.1 million by the trial court. In today's ruling, the 14th Court of Appeals reversed the jury's determination and said Mr. Ernst's widow deserves nothing.

With offices in Los Angeles, Palo Alto, Houston and New York, The Lanier Law Firm is committed to addressing client concerns with effective and innovative solutions in courtrooms across the country. The firm is composed of outstanding trial attorneys with decades of experience handling cases involving personal injury, pharmaceutical liability, asbestos exposure, intellectual property, business litigation, product liability, toxic exposure and maritime law.

For more information, please contact Bruce Vincent at 214.559.4630 office, 214.728.6747 cell, or bruce@androvett.com.


'/>"/>
SOURCE The Lanier Law Firm
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Lanier Law Firm Announces $4.85 Billion National Vioxx Settlement With Merck & Co. Inc.
2. Asbestos Verdict Upheld by Louisiana Court of Appeal, Announces Baron & Budd
3. World Vision Appealing for $2 Million for Deadly China Quake
4. Los Angeles Based Operation USA Appeals for Funds to Aid in Myanmar (Burmese) Cyclone Disaster (Updated)
5. Vion Pharmaceuticals to Appeal Nasdaq Delisting
6. PCMA: Court of Appeals Upholds Challenge to D.C.s PBM Fiduciary-Disclosure Law
7. R.J. Reynolds Tobacco Company Wins Appeal in Lights Case
8. Labopharm Appeals FDAs Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy
9. Court of Appeals Reverses Lower Court Decision in Favor of TriMed, Inc. Patent Infringement Case
10. Closer Analysis Shows Consumer Groups Make Gains in Stem Cell Patent Challenges Against WARF; Appeal Still Planned Against Narrowed Claims
11. SEIU Healthcare Workers to Appeal During Super Bowl for Free and Fair Union Elections in Boston Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... , ... April 21, 2017 , ... Providing broad access ... in opposition, but there is a better way to address this problem. , That ... of Pharmacy, Public Policy and Economics at the University of Southern California, who served ...
(Date:4/21/2017)... ... , ... Brady (NYSE:BRC), a global leader in industrial and safety ... vinyl label materials received certification for the BS5609 British Marine Standard. This internationally ... legible, for use on chemical drums shipped by sea. , “Achieving BS5609 ...
(Date:4/21/2017)... ... April 21, 2017 , ... The VIA Agency , ... for Theravent, Inc. , the makers of a revolutionary new device clinically ... is now working to expand distribution in anticipation of a national launch. VIA ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... ... April 21, 2017 , ... BrightStar Care Salt Lake City, a home ... of Utah (APCUT) and has appointed Rex Wheeler as its new Director of Business ... our agency and our ability to provide quality care to the community,” said Tammara ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: